Citizens analyst Aaron Kimson lowered the firm’s price target on Blend Labs (BLND) to $4 from $5 and keeps an Outperform rating on the shares. Blend Labs reported strong Q1 results, and while guidance for Q2 was disappointing, Citizens continues to like Blend as Autopilot appears to have product market fit and a real path to monetization with 65 lenders in the free beta ending June 30, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLND: